Daniel Gottlieb
InvestorInvestor at Broadview Ventures · Board director at Cardiosense · Board director at XII Medical
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Daniel
279 people in our graph share verified history with Daniel — schools, employers, funds. One of them is your warm intro.
Eghosa OmoiguiunlockedDaniel: together at University of Pennsylvania (1992)
×5Daniel: together at University of Pennsylvania
×4Daniel: together at Guidant Corporation
×2Daniel: together at The Tuck School of Business at Dartmouth
About
Managing Director leading the MedTech practice and overseeing investment operations. Career focused on cardiovascular device and biotech commercialization, with prior roles at Proteon Therapeutics, Abbott Vascular, and Guidant.
Contact· self-published, not guessed
Board director at Cardiosense
Intro paths
→
In turn, Daniel can intro founders to Cardiosense's investors below.
Cardiosense's investors · 8
Arboretum VenturesAnn Arbor · $5M – $15M checks · since 2022BayMed Venture PartnersSan Francisco · since 2022Broadview VenturesBoston · since 2022Cross-Border Impact VenturesToronto · $2M – $10M checks · since 2022Hatteras Venture PartnersResearch Triangle · $500K – $4M checks · since 2022Laerdal Million Lives FundSan Francisco · $1M – $5M checks · since 2022OSF VenturesPeoria · since 2022Portal InnovationsChicago · since 2022
Co-founders at Cardiosense
OI
Omer InanCo-founder, Chief Scientific Officer
AC
Andrew CarekCo-founder, Chief Technical Officer
AG
Amit GuptaCo-founder, Advisor
ME
Mozziyar EtemadiCo-founder, Head of AI
OI
Omer Inan, PhDCo-founder, Chief Scientific Officer
AC
Andrew Carek, PhDCo-founder, Chief Technical Officer
Board director at XII Medical
Intro paths
→
In turn, Daniel can intro founders to XII Medical's investors below.
Experience
- Broadview Ventures IncManaging Directorcurrent2026 — present
- Broadview Ventures IncDirector2019 — 2026Boston, MA
- Longview VenturesDirectorcurrent2019 — present
- XII MedicalBoard of Directorscurrent2021 — present
- CardiosenseBoard of Directorscurrent2022 — presentChicago, Illinois, United States
- Alleviant MedicalBoard of Directorscurrent2025 — present
- CroiValveBoard of Directorscurrent2019 — presentDublin City, County Dublin, Ireland
- CorFlowBoard Observercurrent2024 — present
- Nyra MedicalBoard Observercurrent2022 — presentAtlanta, Georgia, United States
- Puzzle Medical Devices Inc.Board Observer2022 — 2023Montreal, Quebec, Canada
- NIDOBoard Observer2019 — 2022Needham, Massachusetts, United States
- Proteon TherapeuticsVice President, Marketing and Corporate Development2013 — 2019
- Proteon TherapeuticsSenior Director of Marketing and Business Development2010 — 2013
- Proteon TherapeuticsDirector of Marketing and Business Development2007 — 2010
- Abbott VascularStrategic Marketing Manager, Endovascular Business Unit2006 — 2007
- Guidant Corporation, Compass GroupGroup Manager, Business Development and Corporate Venture Capital2001 — 2006
- Guidant CorporationStrategic Planning and Market Research Associate, Coronary Business Unit1999 — 2001
Skills & more
Start-ups9Medical Devices15Biotechnology5Lifesciences4Business Development3Venture Capital1Product Marketing2Strategy12Strategic Planning1Marketing Strategy2Market Development1Product Launch2
+12 more
Cross-functional Team LeadershipMarket ResearchCompetitive AnalysisPharmaceutical IndustryClinical DevelopmentR&DProduct ManagementCRMDue DiligenceCardiologyProduct DevelopmentManagementFrom Daniel's professional profile.
Investments
Investor
Per curated public sources.
Colleagues at Broadview Ventures
Annabel Chen-Tournoux
Investor at Broadview Ventures
Anubodh Sunny Varshney
Venture Advisor at Broadview Ventures
Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Christopher de Souza
Director at Broadview Ventures
David Milan
Chief Scientific Officer, Leducq Corp at Broadview Ventures
David Prim
Principal at Broadview Ventures
Hewmun Lau
Principal at Broadview Ventures
Network5
Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
David Prim
Principal at Broadview Ventures
Maria Berkman
Partner at Vensana Capital
Thomas Needham
Director, Head of the Biopharma Practice at Broadview Ventures
Investors connected to Daniel in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Daniel Gottlieb?
- Managing Director leading the MedTech practice and overseeing investment operations. Career focused on cardiovascular device and biotech commercialization, with prior roles at Proteon Therapeutics, Abbott Vascular, and Guidant.
- Where does Daniel Gottlieb work?
- Daniel Gottlieb is Investor at Broadview Ventures and Board director at Cardiosense and Board director at XII Medical.
- What check size does Daniel Gottlieb write?
- Daniel Gottlieb typically writes checks of $100K – $5M.
- What companies has Daniel Gottlieb invested in?
- Investments tracked here include Cardiosense.
- Where did Daniel Gottlieb go to school?
- Daniel Gottlieb studied at The Tuck School of Business at Dartmouth (MBA, General Management); University of Pennsylvania (BA, Economics and Political Science).
Same school
Also attended The Tuck School of Business at Dartmouth324
John McCulloughInvestor at OpenView Venture PartnersCarley PhillipsPrincipal at GreycroftM.G. ThibautFormer Chief Financial Officer at DroneDeploy at Scale Venture PartnersLiam DonohueInvestor at .406 VenturesGraham BrooksPartner at .406 VenturesJoanna Skoler GilmanChief Marketing and Communications Officer at .406 Ventures
+ 318 more
Also attended University of Pennsylvania1,415
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire Ventures
+ 1,409 more
